Skip to content

Advertisement

  • Oral presentation
  • Open Access

Myocardial fibrosis by delayed enhancement cardiovascular magnetic resonance and HCV infection in thalassemia major patients

  • 1,
  • 1,
  • 2,
  • 1,
  • 1,
  • 3,
  • 4,
  • 5,
  • 2,
  • 6,
  • 7,
  • 7,
  • 8,
  • 9,
  • 10,
  • 11,
  • 12,
  • 13,
  • 1 and
  • 2
Journal of Cardiovascular Magnetic Resonance201012 (Suppl 1) :O48

https://doi.org/10.1186/1532-429X-12-S1-O48

  • Published:

Keywords

  • Cardiovascular Magnetic Resonance
  • Cardiac Magnetic Resonance
  • Thalassemia
  • Myocardial Fibrosis
  • Delay Enhancement

Introduction

Delayed enhancement (DE) cardiac magnetic resonance (CMR) technique is the only validated non-invasive approach used for detecting myocardial fibrosis. In thalassemia major (TM) patients, myocardial fibrosis has been detected using the DE technique and a positive correlation with anti-HCV antibodies has been described. However, in general HCV-induced cardiomyopathy is still controversial, and its pathogenesis is not well understood.

Purpose

The aim of our study was to verify a possible correlation between myocardial fibrosis detected by DE CMR and chronic HCV infection in a large retrospective cohort of TM patients.

Methods

We analyzed 434 Thalassemia Major (TM) patients (233 males, mean age 31 ± 9 years) consecutively enrolled in the MIOT (Myocardial Iron Overload in Thalassemia) study [1]. CMR was performed using a 1.5 T MR scanner (GE Signa/Excite). Contrast delayed enhanced images were acquired in short vertical, horizontal, and oblique long-axis views from 10 to 18 minutes, after the Gadobutrol (Gadovist®; Bayer Schering Pharma; Berlin, Germany, 0.2 mmoli/Kg) intravenous administration, using a fast gradient-echo inversion recovery sequence. Inversion times were adjusted to null the normal myocardium (from 210 ms to 300 ms) with voxel size of 1.6 × 1.25 × 8.0 mm. DE extent was evaluated visually using a two-point scale: enhancement absent or present. HCV-RNA tests were sensitive enough to detect more than 50 copies/ml.

Results

Ninety out of 434 TM patients (21%) were found to have myocardial fibrosis by DE CMR technique. There was a significant correlation between the presence of myocardial fibrosis and the HCV-RNA positive patients plus the patients with a previous diagnosis of chronic hepatitis C treated by alpha-interferon (P = 0.026).

Conclusion

Our finding supports the hypothesis that HCV infection can be involved in the pathogenesis of myocardial fibrosis in the multitransfused TM patients, who could therefore benefit from therapeutic interventions directed towards the eradication of HCV.

Authors’ Affiliations

(1)
"G Monasterio" Foundation and Institute of Clinical Physiology, CNR, Pisa, Italy
(2)
ARNAS Civico Palermo, Palermo, Italy
(3)
University of Ferrara, Ferrara, Italy
(4)
"V. Cervello" Hospital, Palermo, Italy
(5)
"John Paul II" Catholic University, Campobasso, Italy
(6)
"Sant'Eugenio" Hospital, Roma, Italy
(7)
Cardarelli Hospital, Napoli, Italy
(8)
"Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy
(9)
A.O. "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
(10)
A. Perrino Hospital, Brindisi, Italy
(11)
Presidio Ospedaliero Centrale, Taranto, Italy
(12)
Policlinico di Modena, Modena, Italy
(13)
University of Palermo, Palermo, Italy

References

  1. Ramazzotti A, Pepe A, Positano V, et al: Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging. 2009, 30 (1): 62-8. 10.1002/jmri.21781.View ArticlePubMedGoogle Scholar

Copyright

© Pepe et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Advertisement